Cargando…

Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis

BACKGROUND: Type 2 diabetes mellitus (T2DM) is one of the most common diseases worldwide and insulin insufficiency and insulin resistance are two main metabolic issues connected with it. The dyslipidemia associated with insulin resistance and T2DM is characterized by higher triglycerides (TGs), high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filipova, Elena, Uzunova, Katya, Kalinov, Krassimir, Vekov, Toni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686837/ https://www.ncbi.nlm.nih.gov/pubmed/29163673 http://dx.doi.org/10.1186/s13098-017-0290-5

Ejemplares similares

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
por: Dineva, Stela, et al.
Publicado: (2020)

Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis
por: Filipova, Elena, et al.
Publicado: (2020)

Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
por: Filipova, Elena Pavlova, et al.
Publicado: (2015)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
por: Uzunova, Katya, et al.
Publicado: (2020)

Satisfaction of inpatients with acute coronary syndrome in Bulgaria
por: Ganova-Iolovska, Milka, et al.
Publicado: (2008)

Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study
por: Ganova-Iolovska, Milka, et al.
Publicado: (2009)

Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis
por: Wang, Ben, et al.
Publicado: (2018)

SUN-LB47 Extended Release Octreotide Pharmacokinetics in Healthy Subjects After Subcutaneous Injection of MTD201
por: Seaman, Paul, et al.
Publicado: (2020)

COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury
por: Filev, Rumen, et al.
Publicado: (2022)

Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
por: Filev, Rumen, et al.
Publicado: (2022)

Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease
por: Filev, Rumen, et al.
Publicado: (2023)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

Misleading indexed hemodynamic parameters: the clinical importance of discordant BMI and BSA at extremes of weight
por: Adler, Adam C, et al.
Publicado: (2012)

Changes in weight and BMI with first-line doravirine-based therapy
por: Orkin, Chloe, et al.
Publicado: (2021)

Estimation of parameters for a humidity-dependent compartmental model of the COVID-19 outbreak
por: Farkas, Csaba, et al.
Publicado: (2021)

Saccharomyces cerevisiae Linker Histone—Hho1p Maintains Chromatin Loop Organization during Ageing
por: Uzunova, Katya, et al.
Publicado: (2013)

Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs
por: Zhao, Yan, et al.
Publicado: (2022)

Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis
por: Patsalos, Olivia, et al.
Publicado: (2020)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Virulence Factors of the Gut Microbiome Are Associated with BMI and Metabolic Blood Parameters in Children with Obesity
por: Murga-Garrido, S. M., et al.
Publicado: (2023)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
por: Xu, Yifeng, et al.
Publicado: (2017)

The efficacy and safety of pioglitazone in psoriasis vulgaris: A meta-analysis of randomized controlled trials
por: Chen, Pengfei, et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Longitudinal weight differences, gene expression, and blood biomarkers in BMI discordant identical twins
por: van Dongen, Jenny, et al.
Publicado: (2015)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
por: Wojciechowski, P., et al.
Publicado: (2012)

Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A Systematic Review and Meta-Analysis
por: Patsalos, Olivia, et al.
Publicado: (2020)

Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
por: Liao, Hung‐Wei, et al.
Publicado: (2018)

The Low-Dose (7.5 mg/day) Pioglitazone Therapy
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
por: Yamanouchi, Toshikazu
Publicado: (2010)

A pilot dose finding study of pioglitazone in autistic children
por: Capano, Lucia, et al.
Publicado: (2018)

BMI, a Performance Parameter for Speed Improvement
por: Sedeaud, Adrien, et al.
Publicado: (2014)

Pioglitazone-Induced Acute Rhabdomyolysis
por: Slim, Raoudha, et al.
Publicado: (2009)

Investigation of the antibacterial activity of pioglitazone
por: Masadeh, Majed M, et al.
Publicado: (2011)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Pioglitazone: A prudent prescription
por: Kalra, Sanjay, et al.
Publicado: (2013)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcj48vp3e799nd6av85hl7bh15